Evaluation and management of gestational trophoblastic disease

Community Oncology

Volumn 3, Issue 3, 2006, Pages 152-156

  Leiser, Aliza L ^a   Aghajanian, Carol ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CHORIOCARCINOMA; DISEASE CONTROL; GESTATIONAL AGE; HUMAN; HYDATIDIFORM MOLE; STILLBIRTH; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

EID: 33645018563     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70673-8     Document Type: Article

References (25)

1. Soper JT, Mutch DG, Schink JC; American College of Obstetricians and Gynecologists. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol 2004;93:575-585.
2. FIGO Oncology Committee Report. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 2002;77:285-287.
3. Schlaerth JB, Morrow CP, Montz FJ, d'Ablaing G. Initial management of hydatidiform mole. Am J Obstet Gynecol 1988;158(6 pt 1):1299-1306.
4. DuBeshter B, Berkowitz RS, Goldstein DP, Cramer DW, Bernstein MR. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol 1987;69(3 pt 1):390-395.
5. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-779.
6. Johns J, Greenwold N, Buckley S, Jauniaux E. A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound Obstet Gynecol 2005;25:493-497.
7. Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000;16:188-191.
8. Sebire NJ. The diagnosis of gestational trophoblastic disease in early pregnancy: implications for screening, counseling and management. Ultrasound Obstet Gynecol 2005;25:421-424.
9. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 2000;78 (3 pt 1):309-312.
10. Soper JT, Lewis Jr JL, Hammond CB. Gestational trophoblastic disease. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997:1039-1077.
11. Berkowitz RS, Goldstein DP, Bernstein MR. Management of nonmetastatic trophoblastic tumors. J Reprod Med 1981;26:219-222.
12. Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003;101:732-736.
13. Parazzini F, Cipriani S, Mangili G, et al. Oral contraceptives and risk of gestational trophoblastic disease. Contraception 2002;65:425-427.
14. Cole LA, Sutton JM. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. J Reprod Med 2004;49:545-553.
15. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol 1973;115:451-457.
16. Osborne R, Gerulath A. What is the best regimen for low-risk gestational trophoblastic neoplasia? a review. J Reprod Med 2004;49:602-616.
17. Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol 1991;98:550-557.
18. Soto-Wright V, Goldstein DP, Bernstein MR, Berkowitz RS. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Gyneco Oncol 1997;64:156-159.
19. Lurain JR, Nejad B. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97:618-623.
20. Pezeshki M, Hancock BW, Silcocks P, et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol 2004;95:423-429.
21. Soper JT. Role of surgery and radiation therapy in the management of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 2003;17:943-957.
22. Matsui H, Iitsuka Y, Suzuka K, Yamazawa K, Seki K, Sekiya S. Outcome of subsequent pregnancy after treatment for persistent gestational trophoblastic tumour. Hum Reprod 2002;17:469-472.
23. Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med 2002;47:380-386.
24. Tuncer ZS, Bernstein MR, Wang J, Goldstein DP, Berkowitz RS. Repetitive hydatidiform mole with different male partners. Gynecol Oncol 1999;75:224-226.
25. Woolas RP, Bower M, Newlands ES, Seckl M, Short D, Holden L. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol 1998;105:1032-1035.